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Introduction
Medication-overuse headache (MOH) is a secondary form
of chronic headache developed by migraineurs after pro-
longed symptomatic medication overuse. Bio-behavioural
sensitization is a key mechanism in MOH pathophysiol-
ogy, as evidenced by cortical somatosensory evoked poten-
tials (SSEPs) studies. While episodic migraineurs, recorded
between attacks, showed lower initial SSEP amplitudes
and lack of habitation during stimulus repetition, in MOH
patients the SSEPs were initially higher and further
increased during stimulus repetition, resulting in a persis-
tent sensitisation proportional to the duration of the head-
ache chronification phase. The central sensitization seems
to be strongly dependent by glutamate. Amongst various
gene polymorphisms in the glutamatergic system, only the
Glutamate Receptor Ionotropic AMPA 3 (GRIA3) was
previously associated with migraine. The aim of our study
was to verify whether GRIA3 rs3761555 single nucleotide
polymorphism (SNP) could influence processes of central
sensitization of MOH patients.
Methods
We measured SSEP amplitudes as a marker of sensitiza-
tion, and SSEP habituation over two sequential blocks
during uninterrupted peripheral stimulation in a well-
characterized group of 60 MOH patients who underwent
GRIA3 rs3761555 polymorphism analysis.
Results
Sixty (47 females) MOH patients were enrolled in the
study: 27 (9 males) resulted as T/T and 26 C/T and 7
(4 males) T/T. In the comparison among the three gen-
otypes, the grand average of all the neurophysiological
data did not emerge in terms of latencies and ampli-
tudes. The analysis of block amplitude averages showed
differences in SSEP 1st (p = 0.028) and 3rd (p = 0.023)
block amplitude.
Discussion
Our findings are consistent with the hypothesis that the
glutamatergic system influences central sensitization pro-
cesses in MOH patients, by plastic changes in the “pain
matrix”, resulting in decreased nociceptive thresholds,
increased responsiveness to peripheral stimuli and expan-
sion of the receptive fields of central nociceptors. These
phenomena are at the base of migraine chronification,
maybe due to the higher levels of glutamate, as it is mea-
sured in the CSF of chronic migraineurs. Indeed, we
observed that although MOH patients overall had notor-
iously larger SSEP 1st block amplitude than controls, and
deficient habituation, GRIA3 rs3761555 SNP influenced
the amplitude of blocks, according to a decreasing gradient
from T/T to C/C subjects. Although the analyzed SNP
functional consequences are unknown, it was highlighted
as somehow implicated in migraine pathophysiology in
two independent cohorts of patients, maybe by an altered
transcriptional activity. Hitherto, we are not aware of
other disorders potentially related to this SNP.
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